Perrigo Sets Generic Mucinex Launch After Patent Claim Decision
This article was originally published in The Tan Sheet
Executive Summary
The private labeler clears a Reckitt Benckiser legal hurdle and will launch generic Mucinex (guaifenesin) by April. Watson has filed ANDAs for three Mucinex products and could be a good strategic partner for Perrigo, an analyst suggests.
You may also be interested in...
Sales & Earnings In Brief
MiraLAX, Zegerid lead Merck OTCs
Perrigo Takes Two Steps Forward: Generic Allegra Launch, Manufacturing Compliance
Perrigo stokes momentum behind already healthy sales growth with significant steps in separate areas: a green light for regulatory compliance at its main manufacturing plant, and the launch of its generic OTC versions of Sanofi-Aventis' Allegra.
Sales & Earnings In Brief
Watson to push FDA on Mucinex ANDAs